Inventor
JEAN-MAIRET JOËL
ES12 patents
⚠️ This page may combine multiple inventors who share the name “JEAN-MAIRET JOËL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INBIOMOTION SL
6 patentsUS10119171B2Nov 6, 2018
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL14 citations91
US10114022B2Oct 30, 2018
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL14 citations91
US11041213B2Jun 22, 2021
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL9 citations84
US11041861B2Jun 22, 2021
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL9 citations84
US11892453B2Feb 6, 2024
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL0 citations61
US11840740B2Dec 12, 2023
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
INBIOMOTION SL0 citations61
UMAÑA PABLO
3 patentsUS9139654B2Sep 22, 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
US9068005B2Jun 30, 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
US8999324B2Apr 7, 2015
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
UMAÑA PABLO4 citations83
ROCHE GLYCART AG
3 patentsUS9321843B2Apr 26, 2016
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG3 citations72
US9718885B2Aug 1, 2017
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG0 citations51
US9631023B2Apr 25, 2017
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
ROCHE GLYCART AG0 citations51